Ravelli A, Martini A. Juvenile Idiopathic Arthritis. The Lancet. 2007;369:767–78. https://doi.org/10.1016/S0140-6736(07)60363-8.

Article  CAS  Google Scholar 

Berntson L, Andersson-Gäre B, Fasth A, Herlin T, Kristinsson J, Lahdenne P, Nordig Study group, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol. 2003;30:2275–82.

PubMed  Google Scholar 

Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.

PubMed  Google Scholar 

Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011;63:465–82. https://doi.org/10.1002/acr.20460.

Article  PubMed  Google Scholar 

Chhabra A, Oen K, Huber AM, Shiff NJ, Boire G, Benseler SM, ReACCh-Out Investigators, et al. Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results From a Canadian Cohort. Arthritis Care Res (Hoboken). 2020;72:897–906. https://doi.org/10.1002/acr.23922. Epub 2020 Jun 5.

Article  CAS  PubMed  Google Scholar 

Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Rheumatol. 2019;71:846–63. https://doi.org/10.1002/art.40884. Epub 2019 Apr 25.

Article  PubMed  PubMed Central  Google Scholar 

Pohjankoski H, Kautiainen H, Lauri JV, Puolakka K, Rantalaiho V. Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis. Clin Rheumatol. 2020;39:263–8. https://doi.org/10.1007/s10067-019-04702-2. Epub 2019 Jul 25PMID: 31346886.

Article  PubMed  Google Scholar 

Moreland LW, Margolies G, Heck LW Jr, Saway A, Blosch C, Hanna R, et al. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis. J Rheumatol. 1996;23:1849–55.

CAS  PubMed  Google Scholar 

Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000;342(11):763–9.

Article  CAS  PubMed  Google Scholar 

Yim DS, Zhou H, Buckwalter M, Nestorov I, Peck CC, Lee H. Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis. J Clin Pharmacol. 2005;45:246–56. https://doi.org/10.1177/0091270004271945.

Article  CAS  PubMed  Google Scholar 

Langley RG, Kasichayanula S, Trivedi M, Aras GA, Kaliyaperumal A, Yuraszeck T, et al. Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis. J Clin Pharmacol. 2018;58:340–6. https://doi.org/10.1002/jcph.1029. Epub 2017 Nov 6.

Article  CAS  PubMed  Google Scholar 

Zhou H, Mayer PR, Wajdula J, Fatenejad S. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis. J Clin Pharmacol. 2004;44:1235–43. https://doi.org/10.1177/0091270004268049.

Article  CAS  PubMed  Google Scholar 

Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;22(317):1089. https://doi.org/10.1056/NEJM198710223171717.

Article  Google Scholar 

Kneepkens EL, Krieckaert CL, van der Kleij D, Nurmohamed MT, van der Horst-Bruinsma IE, Rispens T, et al. Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up. Ann Rheum Dis. 2015;74:1825–9. https://doi.org/10.1136/annrheumdis-2014-205213. Epub 2014 May 7.

Article  CAS  PubMed  Google Scholar 

Sanmarti R, Inciarte-Mundo J, Estrada-Alarcon P, Garcia-Manrique M, Narvaez J, Rodriguez-Moreno J, et al. Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study. Ann Rheum Dis. 2015;74:e42. https://doi.org/10.1136/annrheumdis-2015-207530. Epub 2015 Mar 24.

Article  CAS  PubMed  Google Scholar 

Gehin JE, Syversen SW, Warren DJ, Goll GL, Sexton J, Bolstad N, et al. Serum etanercept concentrations in relation to disease activity and treatment response assessed by ultrasound, biomarkers and clinical disease activity scores: results from a prospective observational study of patients with rheumatoid arthritis. RMD Open. 2021;7(3):e001985. https://doi.org/10.1136/rmdopen-2021-001985. PMID: 34911811; PMCID: PMC8679136.

Article  PubMed  PubMed Central  Google Scholar 

Griffiths CEM, Thaçi D, Gerdes S, Arenberger P, Pulka G, Kingo K, et al. EGALITY study group: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis. Br J Dermato. 2017;176:928–38 Epub 2017 Mar 1.

Article  CAS  Google Scholar 

Onel K, Horton D, Lovell D, Shenoi S, Cuello C, Angeles-Han S, et al. 2021 American college of rheumatology guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for oligoarthritis, tempomandibular joint arthritis, and systemic idiopathis arthritis. Arthritis Rheumatol. 2022;74(4):553–69. https://doi.org/10.1002/acr.24839. Epub 2022 Mar 1PMID: 35233989.

Article  PubMed  Google Scholar 

Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva Ð, et al. Paediatric Rheumatology International Trials Organisation (PRINTO), BiKeR and the board of the Swedish Registry. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries. Arthritis Res Ther. 2018;27(20):285018–1780-z. https://doi.org/10.1186/s13075-018-1780-z.

Article  CAS  Google Scholar 

Armaroli G, Klein A, Ganser G, Ruehlmann MJ, Dressler F, Hospach A, et al. Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry. Arthritis Res Ther. 2020;22(1):258,020-0232. https://doi.org/10.1186/s13075-020-02326-5.

Article  CAS  Google Scholar 

Alcobendas R, Rodriguez-Vidal A, Pascual-Salcedo D, Murias S, Remesal A, Diego C, et al. Monitoring serum etanercept levels in juvenile idiopathic arthritis: a pilot study. Clin Exp Rheumatol. 2016;34:955–6.

PubMed  Google Scholar 

Bader-Meunier B, Krzysiek R, Lemelle I, Pajot C, Carbasse A, Poignant S, et al. Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis. Semin Arthritis Rheum. 2019;48:1014–8. https://doi.org/10.1016/j.semarthrit.2018.09.002. Epub 2018 Sep 17.

Article  CAS  PubMed  Google Scholar 

Zhou H. Clinical pharmacokinetics of Etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein. J Clin Pharmacol. 2005;45:490–7. https://doi.org/10.1177/0091270004273321.

Article  CAS  PubMed  Google Scholar 

Temrikar ZH, Suryawanshi S, Meibohm B. Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodeis in Pediatric Patients. Paediatr Drugs. 2020;22:199–216. https://doi.org/10.1007/s40272-020-00382-7.

Article  PubMed  PubMed Central  Google Scholar 

Verstegen RHJ, McMillian R, Feldman BM, Ito S, Laxer RM. Towards therapeutic drug monitoring of TNF inhibitors for children with juvenile idiopathic arthritis: a scoping review. Rheumatology (Oxford). 2020;59:386–97. https://doi.org/10.1093/rheumatology/kez285.

Article  CAS  PubMed  Google Scholar 

Giani T, De Masi S, Maccora I, Tirelli F, Simonini G, Falconi M, et al. The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis. Front Pharmacol. 2019;10:637. https://doi.org/10.3389/fphar.2019.00637. eCollection 2019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balevic SJ, Becker ML, Gonzalez D, Funk RS. Low etanercept concentrations in children with obesity and juvenile idiopathic arthritis. J Pediatr Pharmacol Ther. 2021;26:809–14. https://doi.org/10.5863/1551-6776-26.8.809. Epub 2021 Nov 10.

Article  PubMed  PubMed Central  Google Scholar 

Van Bezooijen JS, Schreurs MWJ, Koch BCP, Velthuis HT, van Doorn MBA, Prens EP, et al. Intrapatient Variability in the Pharmacokinetics of Etanercept Maintenance Treatment. Ther Drug Monit. 2017;39:333–8. https://doi.org/10.1097/FTD.0000000000000384.

Article  CAS  PubMed  Google Scholar 

Nassar-Sheikh RA, Schonenberg-Meinema D, Bergkamp SC, Bakhlakh S, de Vries A, Rispens T, et al. Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA). Pediatr Rheumatol Online J. 2021;19:59. https://doi.org/10.1186/s12969-021-00545-x.

Article  Google Scholar 

Deng Y, Hu L, Qiang W, Cheng Z, Wang L, Wang X. TNF-α level affects etanercept clearance: TNF- α concentration as a new correction factor of allometric scaling to predict individual etanercept clearances in patients with ankylosing spondylitis. Clin Exp Pharmacol Physiol. 2018;45:643–51. https://doi.org/10.1111/1440-1681.12924. Epub 2018 Mar 11.

Article  CAS  PubMed  Google Scholar 

Berkhout LC, l’Ami MJ, Krieckaert CLM, Vogelzang EH, Kos D, Nurmohamed MT, et al. The effect of methotrexate on tumour necrosis factor concentrations in etanercept-treated rheumatoid arthritis patients. Rheumatology (Oxford). 2020;(59):1703–8. https://doi.org/10.1093/rheumatology/kez513.

Article  CAS  PubMed  Google Scholar